Fatal hemolytic disease of the newborn caused by an antibody to KEAL, a new low-prevalence Kell blood group antigen.
Red Cross Blood Service of Baden-Württemberg-Hessen, Institute Baden-Baden, Baden-Baden, Germany.
Erwin A
EA
Scharberg
Institute of Transfusion Medicine and Immunology, Heidelberg University, Medical Faculty Mannheim, German Red Cross Blood Service Baden-Württemberg-Hessen, Mannheim, Germany.
Carola
C
Wieckhusen
Klinikum Stuttgart, Institute of Transfusion Medicine.
Beate
B
Luz
Red Cross Blood Service of Baden-Württemberg-Hessen, Institute Baden-Baden, Baden-Baden, Germany.
Sina
S
Rothenberger
Red Cross Blood Service of Baden-Württemberg-Hessen, Institute Baden-Baden, Baden-Baden, Germany.
Annette
A
Stürzel
Institute of Transfusion Medicine and Immunology, Heidelberg University, Medical Faculty Mannheim, German Red Cross Blood Service Baden-Württemberg-Hessen, Mannheim, Germany.
Gabi
G
Rink
Red Cross Blood Service of Baden-Württemberg-Hessen, Institute Baden-Baden, Baden-Baden, Germany.
Ekkehard
E
Richter
Olgahospital, Klinikum Stuttgart, Stuttgart, Germany.
Loredana
L
Delle Chiaie
New York Blood Center, New York, New York.
Anna
A
Burgos
New York Blood Center, New York, New York.
Christine
C
Lomas-Francis
Institute of Transfusion Medicine and Immunology, Heidelberg University, Medical Faculty Mannheim, German Red Cross Blood Service Baden-Württemberg-Hessen, Mannheim, Germany.
Peter
P
Bugert
D000328:Adult; D000906:Antibodies / Q000276:immunology*; D004899:Erythroblastosis, Fetal / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D005091:Exons / Q000235:genetics; D005260:Female; D006801:Humans; D007626:Kell Blood-Group System / Q000235:genetics* / Q000276:immunology; D008297:Male; D010375:Pedigree
D000906:Antibodies; D007626:Kell Blood-Group System